Company intelligence / Profile preview

HG2 Capital Corp.

Toronto, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

HG2 Capital Corp. is a Toronto-based merchant bank and investment firm specializing in the healthcare, life sciences, and cannabis sectors. Led by prominent entrepreneur Lorne Gertner, the company provides capital formation, strategic advisory, and investment services to both private and public mid-market companies. HG2 Capital is recognized for its early and significant role in the legal cannabis industry, with its leadership having co-founded major entities such as Cronos Group (formerly PharmaCan Capital) and Tokyo Smoke. The firm focuses on identifying high-growth opportunities in cannabinoid-based wellness, medical technologies, and biotechnology.

Industry: Investors

Partnerships

CB1 Capital ManagementiCAN: Israel-CannabisFyllo

Beyond the preview

Go deeper on HG2 Capital Corp..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HG2 Capital Corp..

Explore the full profile